Muscle carnosine is associated with cardiometabolic risk factors in Humans

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  De Courten, Barbora ^a   Kurdiova, Timea ^b   De Courten, Maximilian P J ^c   Belan, Vitazoslav ^d   Everaert, Inge ^e   Vician, Marek ^f   Teede, Helena ^a   Gasperikova, Daniela ^b   Aldini, Giancarlo ^g   Derave, Wim ^e   Ukropec, Jozef ^b   Ukropcova, Barbara ^b,h   Moro, Cedric ⁱ  

^a MONASH UNIVERSITY   (Australia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c VICTORIA UNIVERSITY   (Australia)

^d UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^e GHENT UNIVERSITY   (Belgium)

^f SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^g UNIVERSITY OF MILAN   (Italy)

^h INSERM/UMR 1048 ^*  (Slovakia)

ⁱ INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL SUBCUTANEOUS FAT; ACCELEROMETER; ADULT; ARTICLE; BODY FAT; CALORIMETRY; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMPEDANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; MUSCLE LEVEL; NEEDLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHYSICAL ACTIVITY; RESTING ENERGY EXPENDITURE; VASTUS LATERALIS MUSCLE; BLOOD; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MOTOR ACTIVITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; RISK FACTOR; SKELETAL MUSCLE;

ADULT; CARNOSINE; CHOLESTEROL, HDL; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE, SKELETAL; RISK FACTORS;

EID: 84947756365     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138707     Document Type: Article

References (49)

1. Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 8: 228-236.
2. Zimmet P, Alberti KG, Shaw J. (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787. PMID: 11742409
3. Baguet A, Everaert I, Yard B., Peters V, Zschocke J, et al (2014) Does low serum carnosinase activity favor high-intensity exercise capacity? J Appl Physiol 116: 553-559. doi: 10.1152/japplphysiol.01218. 2013 PMID: 24408989
4. Boldyrev A, Fedorova T, Stepanova M., Dobrotvorskaya I, Kozlova E, et al (2008) Carnosine [corrected] increases efficiency of DOPA therapy of Parkinson's disease: a pilot study. Rejuvenation Res 11: 821-827. doi: 10.1089/rej.2008.0716 PMID: 18729814
5. Chengappa KN, Turkin SR, DeSanti S, Bowie C.R., Brar JS, et al. (2012) A preliminary, randomized, double-blind, placebo-controlled trial of L-carnosine to improve cognition in schizophrenia. Schizophr Res 142:145-152. doi: 10.1016/j.schres.2012.10.001 PMID: 23099060
6. Chez MG, Buchanan CP, Aimonovitch M.C., Becker M., Schaefer K, et al. (2002) Double-blind, placebocontrolled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 17: 833-837. PMID: 12585724
7. del Favero S., Roschel H, Solis MY, Hayashi A.P., Artioli GG, et al. (2012) Carnosyn supplementation in elderly subjects (60-80 years): effects on muscle carnosine content and physical capacity. Amino Acids 43: 49-56.
8. Slowinska-Lisowska M., Zembron-Lacny A, Rynkiewicz M., Rynkiewicz T, Kopec W. (2014) Influence of l-carnosine on pro-antioxidant status in elite kayakers and canoeists. Acta Physiol Hung 101: 461-470. doi: 10.1556/APhysiol.101.2014.008 PMID: 25201708
9. Vozarova B, Stefan N, Hanson R., Lindsay RS, Bogardus C, et al. (2002) Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia 45:1739-1741. PMID: 12552367
10. Vozarova B, Weyer C, Lindsay R.S., Pratley RE, Bogardus C, et al. (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455-461. PMID: 11812755
11. Aldini G, Carini M, Beretta G., Bradamante S, Facino R.M. (2002) Carnosine is a quencher of 4-hydroxynonenal: through what mechanism of reaction? Biochem Biophys Res Commun 298: 699-706. PMID: 12419310
12. Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803-1845. doi: 10.1152/physrev.00039.2012 PMID: 24137022
13. Hipkiss AR, Michaelis J, Syrris P. (1995) Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371: 81-85. PMID: 7664889
14. Lee YT, Hsu CC, Lin M.H., Liu KS, Yin M.C. (2005) Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. EurJ Pharmacol 513: 145-150. PMID: 15878720
15. Pavlov AR, Revina AA, Dupin A.M., Boldyrev AA, Yaropolov A.I. (1993) The mechanism of interaction of carnosine with superoxide radicals in water solutions. BiochimBiophysActa 1157: 304-312. PMID: 8391845
16. Vozarova B, Weyer C, Hanson K, Tataranni P.A., Bogardus C, et al (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research 9: 414-417. PMID: 11445664
17. Forbes JM, Sourris KC, deCourten M.P., Dougherty SL, Chand V, et al. (2014) Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. Amino Acids 46: 321-326. doi: 10.1007/s00726-013-1542-9 PMID: 23832534
18. Mark AB, Poulsen MW, Andersen S, Andersen J.M., Bak MJ, et al (2014) Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care 37: 88-95. doi: 10.2337/dc13-0842 PMID: 23959566
19. Niijima A, Okui T, Matsumura Y, Yamano T., Tsuruoka N, et al. (2002) Effects of L-carnosine on renal sympathetic nerve activity and DOCA-salt hypertension in rats. Auton Neurosci 97: 99-102. PMID: 12132650
20. Yapislar H, Taskin E. (2014) L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats. Med Sci Monit 20: 399-405. doi: 10.12659/MSM.890528 PMID: 24614724
21. Aldini G, Granata P, Carini M. (2002) Detoxification of cytotoxic alpha, beta-unsaturated aldehydes by carnosine: characterization of conjugated adducts by electrospray ionization tandem mass spectrometry and detection by liquid chromatography/mass spectrometry in rat skeletal muscle. J Mass Spectrom 37:1219-1228. PMID: 12489081
22. Aldini G, Facino RM, Beretta G, Carini M. (2005) Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors 24: 77-87. PMID: 16403966
23. Aldini G, Orioli M, Rossoni G., Savi F, Braidotti P, et al (2011) The carbonyl scavenger carnosine ameliorates dyslipidaemiaand renal function in Zucker obese rats. J Cell Mol Med 15:1339-1354. doi: 10.1111/j.1582-4934.2010.01101.x PMID: 20518851
24. Baba SP, Hoetker JD, Merchant M, Klein J.B., Cai J., et al. (2013) Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates. J Biol Chem 288: 28163-28179. doi: 10.1074/jbc.M113.504753 PMID: 23928303
25. Nagai K, Tanida M, Niijima A., Tsuruoka N, Kiso Y, et al (2012) Role of L-carnosine in the control of blood glucose, blood pressure, thermogenesis, and lipolysis by autonomic nerves in rats: involvement of thecircadian clock and histamine. Amino Acids 43: 97-109. doi: 10.1007/s00726-012-1251-9 PMID: 22367578
26. Orioli M, Aldini G, Benfatto M.C., Facino RM, Carini M. (2007) HNE Michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: LC-MS/MS profiling in Zucker obese rats. Anal Chem 79:9174-9184. PMID: 17979257
27. Pfister F, Riedl E, Wang Q., vom Hagen F, Deinzer M, et al (2011) Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell Physiol Biochem 28:125-136. doi: 10.1159/000331721 PMID: 21865855
28. Riedl E, Pfister F, Braunagel M., Brinkkotter P, Sternik P, et al (2011) Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell Physiol Biochem 28: 279-288. doi: 10.1159/000331740 PMID: 21865735
29. Sauerhofer S, Yuan G, Braun G.S., Deinzer M, Neumaier M., et al. (2007) L-carnosine, a substrate of carnosinase-1, influences glucose metabolism. Diabetes 56: 2425-2432. PMID: 17601992
30. Soliman KM, Abdul-Hamid M, Othman A.I. (2007) Effect of carnosine on gentamicin-induced nephrotoxicity. Med Sci Monit 13: BR73-83. PMID: 17325631
31. Szwergold BS (2005) Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochem Biophys Res Commun 336: 36-41. PMID: 16112643
32. Lombardi C, Carubelli V, Lazzarini V., Vizzardi E, Bordonali T, et al (2015) Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heartfailure. Nutrition 31: 72-78. doi: 10.1016/j.nut.2014.04.021 PMID: 25287762
33. Srikanthan P, Singhal A, Lee C.C., Nagarajan R., Wilson N, et al. (2012) Characterization of Intra-myocellular Lipids using 2D Localized Correlated Spectroscopy and Abdominal Fat using MRI in Type 2 Diabetes. Magn Reson Insights 5: 29-36. PMID: 23471581
34. Gualano B, Everaert I, Stegen S., Artioli GG, Taes Y, et al. (2012) Reduced muscle carnosine content in type 2, but not in type 1 diabetic patients. Amino Acids 43: 21-24. doi: 10.1007/s00726-011-1165-y PMID: 22120670
35. Stegen S, Everaert I, Deldicque L., Vallova S, Ukropcova B, et al (2015) Muscle histidine-containing dipeptides in relation to glucose intolerance Plos One in press
36. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M., et al. (2014) Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 592:1091-1107. doi: 10.1113/jphysiol.2013.264655 PMID: 24297848
37. Geiselman PJ, Anderson AM, Dowdy M.L., West DB, Redmann SM, et al. (1998) Reliability and validity of a macronutrient self-selection paradigm and a food preference questionnaire. Physiol Behav 63: 919-928. PMID: 9618017
38. Despres JP, Lemieux I, Dagenais G.R., Cantin B., Lamarche B. (2000) HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study. Atherosclerosis 153: 263-272. PMID: 11164415
39. Quinn PJ, Boldyrev AA, Formazuyk V.E. (1992) Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 13: 379-444. PMID: 9765790
40. Nagai K, Niijima A, Yamano T., Otani H, Okumra N, et al (2003) Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves. Exp Biol Med (Maywood) 228:1138-1145.
41. Cheng KK, Akasaki Y, Lecommandeur E., Lindsay RT, Murfitt S, et al (2014) MetabolomicAnalysis of Akt1-Mediated Muscle Hypertrophy in Models of Diet-Induced Obesity and Age-Related Fat Accumulation. J Proteome Res.
42. Tallon MJ, Harris RC, Maffulli N, Tarnopolsky M.A. (2007) Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects. Biogerontology 8:129-137. PMID: 16967207
43. Stuart CA, McCurry MP, Marino A, South M.A., Howell ME, et al. (2013) Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab 98: 2027-2036. doi: 10.1210/jc.2012-3876 PMID: 23515448
44. Kim MY, Kim EJ, Kim Y.N., Choi C., Lee BH (2011) Effects of alpha-lipoic acid and L-carnosine supplementation on antioxidant activities and lipid profiles in rats. NutrRes Pract 5: 421-428. doi: 10.4162/nrp.2011.5.5.421 PMID: 22125679
45. Ririe DG, Roberts PR, Shouse MN, Zaloga GP (2000) Vasodilatory actions of the dietary peptide carnosine. Nutrition 16: 168-172. PMID: 10705070
46. Aydin AF, Kusku-Kiraz Z, Dogru-Abbasoglu S, Uysal M. (2010) Effect of carnosine treatment on oxidative stress in serum, apoB-containing lipoproteins fraction and erythrocytes of aged rats. Pharmacol Rep 62: 733-739. PMID: 20885014
47. Brown BE, Kim CH, Torpy F.R., Bursill CA, McRobb LS, et al. (2014) Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice. Atherosclerosis 232: 403-409. doi: 10.1016/j.atherosclerosis.2013.11.068 PMID: 24468155
48. Greene SM, Margolis FL, Grillo M, Fisher H. (1984) Enhanced carnosine (beta-alanyl-L-histidine) breakdown and histamine metabolism following treatment with compound 48/80. Eur J Pharmacol 99:79-84. PMID: 6723792
49. Everaert I, Mooyaart A, Baguet A., Zutinic A, Baelde H, et al (2011) Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans. Amino Acids 40:1221-1229. doi: 10.1007/s00726-010-0749-2 PMID: 20865290